Literature DB >> 7724596

Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration.

T Li1, W K Franson, J W Gordon, E L Berson, T P Dryja.   

Abstract

The missense mutation Lys-296-->Glu (K296E) in the rhodopsin gene produces an opsin with no chromophore binding site and therefore is not activated by light. Nevertheless, the mutant opsin constitutively activates transducin in vitro and causes photoreceptor degeneration in vivo, possibly by continuously activating the phototransduction cascade, analogous to constant exposure to environmental light. We studied the K296E mutation in eight lines of transgenic mice. Each line developed photoreceptor degeneration with the rate of degeneration increasing monotonically as the ratio of mutant:wild-type opsin mRNA increased. At no time in the course of degeneration was there endogenous light adaptation in the retina as measured by the electroretinogram. The mutant opsin was found to be invariably phosphorylated and stably bound to arrestin. Light-independent activation of transducin was demonstrated only after the removal of arrestin and dephosphorylation of K296E opsin. Thus, K296E opsin in vivo does not activate the phototransduction cascade because it is shut off by photoreceptor inactivation mechanisms. Our data show that the K296E mutation does not cause photoreceptor degeneration by continuous activation of phototransduction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724596      PMCID: PMC42205          DOI: 10.1073/pnas.92.8.3551

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Regulation of rhodopsin dephosphorylation by arrestin.

Authors:  K Palczewski; J H McDowell; S Jakes; T S Ingebritsen; P A Hargrave
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

2.  Anti-rhodopsin monoclonal antibodies of defined specificity: characterization and application.

Authors:  G Adamus; Z S Zam; A Arendt; K Palczewski; J H McDowell; P A Hargrave
Journal:  Vision Res       Date:  1991       Impact factor: 1.886

3.  A 52 kD cytoskeletal protein from retinal rod photoreceptors is related to erythrocyte dematin.

Authors:  D Roof; A Hayes; G Hardenbergh; M Adamian
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-03       Impact factor: 4.799

4.  The catalytic subunit of phosphatase 2A dephosphorylates phosphoopsin.

Authors:  K Palczewski; P A Hargrave; J H McDowell; T S Ingebritsen
Journal:  Biochemistry       Date:  1989-01-24       Impact factor: 3.162

5.  Immunocytochemical demonstration of retinal S-antigen in the pineal organ of four mammalian species.

Authors:  H W Korf; M Møller; I Gery; J S Zigler; D C Klein
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

6.  Light-induced binding of 48-kDa protein to photoreceptor membranes is highly enhanced by phosphorylation of rhodopsin.

Authors:  H Kühn; S W Hall; U Wilden
Journal:  FEBS Lett       Date:  1984-10-29       Impact factor: 4.124

7.  Allosteric behavior in transducin activation mediated by rhodopsin. Initial rate analysis of guanine nucleotide exchange.

Authors:  M Wessling-Resnick; G L Johnson
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

8.  Rhodopsin activation causes retinal degeneration in Drosophila rdgC mutant.

Authors:  F Steele; J E O'Tousa
Journal:  Neuron       Date:  1990-06       Impact factor: 17.173

9.  Antigen-antibody interaction. Synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin.

Authors:  R S Hodges; R J Heaton; J M Parker; L Molday; R S Molday
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

10.  Transducin activation by rhodopsin without a covalent bond to the 11-cis-retinal chromophore.

Authors:  E A Zhukovsky; P R Robinson; D D Oprian
Journal:  Science       Date:  1991-02-01       Impact factor: 47.728

View more
  43 in total

1.  Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype?

Authors:  R D Cone
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.

Authors:  Darwin Toledo; Eva Ramon; Mònica Aguilà; Arnau Cordomí; Juan J Pérez; Hugo F Mendes; Michael E Cheetham; Pere Garriga
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 3.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

4.  Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess.

Authors:  Hellevi Peltoketo; Leena Strauss; Riikka Karjalainen; Meilin Zhang; Gordon W Stamp; Deborah L Segaloff; Matti Poutanen; Ilpo T Huhtaniemi
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

Review 5.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

Review 6.  Phototransduction in mouse rods and cones.

Authors:  Yingbin Fu; King-Wai Yau
Journal:  Pflugers Arch       Date:  2007-01-17       Impact factor: 3.657

7.  Arrestin can act as a regulator of rhodopsin photochemistry.

Authors:  Martha E Sommer; David L Farrens
Journal:  Vision Res       Date:  2006-10-27       Impact factor: 1.886

8.  Structure and function of the visual arrestin oligomer.

Authors:  Susan M Hanson; Ned Van Eps; Derek J Francis; Christian Altenbach; Sergey A Vishnivetskiy; Vadim Y Arshavsky; Candice S Klug; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

Review 9.  Constitutively active rhodopsin and retinal disease.

Authors:  Paul Shin-Hyun Park
Journal:  Adv Pharmacol       Date:  2014

10.  A unique pattern of photoreceptor degeneration in cyclin D1 mutant mice.

Authors:  C Ma; D Papermaster; C L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.